PT  - JOURNAL ARTICLE
AU  - Calhas, David
AU  - Henriques, Rui
TI  - EEG to fMRI Synthesis for Medical Decision Support: A Case Study on Schizophrenia Diagnosis
AID  - 10.1101/2023.08.07.23293748
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.08.07.23293748
4099  - http://medrxiv.org/content/early/2023/08/09/2023.08.07.23293748.short
4100  - http://medrxiv.org/content/early/2023/08/09/2023.08.07.23293748.full
AB  - Electroencephalography (EEG) measures the neuronal activity at the scalp, while functional magnetic resonance imaging (fMRI) provides a sub-cortical view of blood supply in the human brain. Although fMRI is known for providing rich spatial information, it is expensive and of restricted use. EEG to fMRI synthesis is a cross modal research area that bridges the gap between the two and has recently received attention. Although these studies promise lower healthcare costs and ambulatory assessments, their utility in diagnostic settings is still largely untapped. Using simultaneous EEG and fMRI recordings, this study combines a state-of-the-art synthesis model with a modified contrastive loss, and subsequent prediction layering, to unprecedentedly assess its predictive power in schizophrenia diagnosis. In addition, we perform an exhaustive search for the (synthesized) hemodynamic brain patterns able to discriminate schizophrenia. Schizophrenia diagnosis using synthesized hemodynamics yield an area under the ROC curve of 0.77, confirming the validity of the undertaken neuroimaging synthesis. Experiments further revealed schizophrenia-related patterns in frontal, left temporal and cerebellum regions of the brain. Altogether, our results suggest that a synthesized fMRI view is able to discriminate this pathology, and it contains discriminative patterns of brain activity in accordance with related work on schizophrenia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by national funds through Funda\c{c}\∽ao para a Ci\^encia e Tecnologia (FCT), under the Ph.D. Grant SFRH/BD/5762-/2020 to David Calhas and INESC-ID pluriannual UIDB/50021/2020Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:https://openneuro.org/datasets/ds004000 and https://osf.io/94c5t/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData used is available at https://openneuro.org/datasets/ds004000 and https://osf.io/94c5t/. https://openneuro.org/datasets/ds004000 https://osf.io/94c5t/